Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.17% to 7692.46, DAX +0.73% to 17845.96, CAC40 +0.77% to 8016.22, STOXX 600 +1.00% to 503.17

Mar 07 ,2024

  • Synopsis:

    • European equity markets mostly closed higher with pan-European indices ending around the best levels of the session. Shares reversed any modest initial declines, with pan-European indices then gradually extending gains, getting a further boost from the ECB policy decision and staff projections, before becoming range-bound onto the close.

    • Greece (0.5%), Austria, Portugal both (0.1%) and Norway, Switzerland both +0.2% led underperformers, with Denmark +5.7%, Netherlands +1.4% and Spain +1.3% leading outperformers

    • ECB interest rate decision saw it keep its benchmark interest rate unchanged, as expected. Among estimate changes made by ECB staff, they revised down inflation projection, in particular for 2024, to +2.3%, and also revised down their growth projection for 2024 to +0.6%

    • Serbia Central Bank left its benchmark interest rate unchanged at 6.5%, as expected. Other central bankers speaking included Bank of Spain's de Cos spoke at jointly organize conf (through Fri). BOE's Benford spoke at the Big Data & AI World conf and Bundesbank's Balz spoke at event jointly organised by Konrad Adenauer Foundation and FIEL

    • Halifax data saw UK house prices rise for the fifth consecutive month in Feb, though an executive struck a note of caution saying there remains a possibility that there could be a slowdown in the housing market this year. Other economic releases included Germany Jan factory orders, Switzerland Feb unemployment rate and Denmark/Norway Jan manufacturing production

    • In UK, analysis and debate of yesterday's budget continued.

    • On the Continent, European People's Party's Congress attracted EU commissioners, MEPs and PMs from across the region as Ursula von der Leyen was formally endorsed as candidate for EU Commission President, in her ambition for a second five-year term, for which she'll need the support of member countries and the EU Parliament. Meeting of heads of government of the German states in Berlin. The afternoon meeting includes Chancellor Scholz, and will focus on migration and refugee policy. A post meeting press conf. is scheduled. EU's Simson delivered a keynote speech and participated in a panel discussion at the Offshore Norge's Annual Conf. EU's Competitive Council discussed a report on the advance of the works to reach an agreement on the late payment regulation.

    • Divisions remain between EU countries on the Middle East as Council President Michel attempts to get the 27 EU leaders to agree common language on the war at next meeting on 21/22-Mar.

    • In Nordics, Norway's PM Støre gave the opening speech at a seminar organized by NIF, Norsk Tipping and Talent Norway, whilst the country's Minister of Energy Aasland participated in a senior management conf. for the Nordic renewables industry

    • Amongst the M&A news flow, Nationwide Building Society announces offer for Virgin Money UK in deal worth ~£2.9B, Iberdrola (IBE.SM) makes a preliminary non-binding offer to acquire remainder of Avangrid (AGR) for $34.25/share in cash and Telefónica (TEF.SM) to make public delisting acquisition offer to shareholders of Telefónica Deutschland Holding (O2D.GR)

    • Among some of the region's leading companies that saw more muted (percentage change) share price reaction to earnings/updates included Aviva (AV.LN) FY net income £1.11B vs year-ago (£1.03B), Eurazeo (RF.FP) FY net income €1.82B vs FactSet €299.2M [3 est, €108.1-500M], raises dividend +10% y/y, announces launch of the new €200M share buyback program for 2024 and Grafton Group (GFTU.LN) FY EPS 77.9p vs FactSet 72.1p [10 est, 61.4-76.0p], says profitability in the first two months was in line with our expectations. Also, Deutsche Lufthansa (LHA.GR) Q4 EPS €0.06 vs FactSet €0.14 [4 est, (€0.19)-0.39]; expects FY24 adj EBIT to be on the same level as in 2023, the company also in the headlines as strikes cripple air and rail travel across Germany, Continental (CON.GR) FY net income €1.16B vs consensus €1.41B; hikes di by ~47% and guides FY24, SFS Group (SFSN.SW) FY net income FY net income CHF268.5M vs FactSet CHF269.4M [8 est, CHF258.5-280.8M], expects FY24 EBIT margin around previous year level and Melrose Industries (MRO.LN) FY EPS from cont. ops 18.7p ex-items vs FactSet 16.8p [11 est, 11.4-18.7p], provides 2024 guidance.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Health Care +2.31%, Technology +2.26%, Basic Resources +1.58%, Construct & Mtls +1.42%, Real Estate+1.39%, Chemicals +1.23%, Utilities +1.02%

      • Underperformers:

        • Travel & Leisure (0.49%), Telecom (0.24%), Oil & Gas (0.11%), Autos & Parts (0.07%), Banks +0.11%, Retail +0.20%, Media +0.38%, Ind Goods & Svcs +0.58%, Food & Beverage +0.60%, Financial Svcs +0.64%, Insurance +0.76%, Persnl & HHold Goods +0.88%

    • Macro/Peripheral markets:

      • Central Banks:

        • ECB monetary policy decision - press release; Staff projection GDP 2024 +0.6% vs prior forecast +0.8%, 2025 +1.5% unchanged and 2026 +1.5% vs prior +1.6%; inflation 2024 +2.3% vs prior +2.7%, 2025 +2.0% vs prior +2.1% and 2026 +1.9%, unchanged - release

        • BOE releases Feb Decision Maker Panel (DMP) survey; One-year ahead CPI inflation expectations declined further - release

        • Serbia Central Bank left its benchmark interest rate unchanged - release

      • Finland:

        • Working group prepares a growth strategy for the financial sector - release

      • Ireland:

        • All sides urge people to vote in tomorrow's referendums amid concern that there could be a low turnout - RTE

      • Norway

        • Will join the letter of intent on support to Ukraine in air defense against aircraft and missiles - release

      • Portugal:

        • Sunday's general election dominated by anger over corruption and country's economy - Reuters; Poll tracker - CNN Portugal; opinion poll - cm

      • UK:

        • Chancellor reverses the policy priorities of the 2010s, rehashes its austerity, and records the first ever polling-day-to-polling-day fall in living standards - Resolution Foundation assessment on yesterday's budget

        • Institute for Fiscal Studies (IFS) Post Budget presentation - opening remarks

        • Chancellor leaves door open to more tax cuts - FT

        • Hunt has refused to rule out the possibility of a May election - LBC

    • Company news:

      • Notable Gainers

        • +55.7% FCH.LN (Funding Circle Holdings) -- FY net income £168.2M, +8% vs year-ago £155.8M; to launch an up to £25M share buyback program

        • +34.8% VMUK.LN (Virgin Money UK) -- Nationwide Building Society announces 218p/share offer for Virgin Money UK in deal worth ~£2.9B

        • +18.2% RTO.LN (Rentokil Initial) -- FY EPS 23.1p vs consensus 22.3p; hikes divi by 15%; raises expectations for annual pre-tax synergies from the Terminix integration

        • +14.2% BANB.SW (Bachem Holding) -- FY net income CHF111.9M vs FactSet CHF106.5M [8 est, CHF100.9-110.9M]; raises dividend +6.7%; provides 2024 guidance

        • +12.0% ITV.LN (ITV)

          • FY adj EPS 7.8p vs FactSet 8.0p [10 est, 7.8-8.4p]; 2026 KPI targets on track; will commence up to £235M share buyback program

          • upgraded to neutral from sell at Goldman Sachs

        • +9.7% PBB.GR (Deutsche Pfandbriefbank) -- FY pretax income €90M vs preliminary €90M and FactSet €91.6M

        • +9.6% RAP1V.FH (Rapala VMC) -- FY EPS (€0.19) vs FactSet (€0.09) [2 est, (€0.10)-(0.07)]

        • +9.0% COA.LN (Coats Group) -- FY adjusted EPS $0.08 vs FactSet $0.08 [8 est, $0.07-0.08], expects to make good progress in 2024 underpinned by modest revenue growth, with a weighting to H2

        • +8.3% NOVO.B.DC (Novo Nordisk)

          • provides progress update on its Strategic Aspirations 2025 - CMD

          • discloses data from phase 1 trial of GLP-1 and amylin co-agonist amycretin

        • +7.2% ONT.LN (Oxford Nanopore Technologies) -- upgraded to hold from sell at Stifel

        • +6.3% AMP.IM (Amplifon) -- Q4 adj EPS €0.28 vs consensus €0.27, guides FY24; announces new 10% buyback program

        • +6.0% SQZ.LN (Serica Energy) -- FY23 reserves and FY24 production update

        • +5.9% TTG.LN (TT Electronics) -- FY adjusted EPS 19.2p vs FactSet 18.2p [8 est, 17.7-18.7p], on track to deliver 10% group operating margin in 2024

        • +5.9% SPIE.FP (SPIE) -- FY adjusted net income €344.0M vs FactSet €337.1M [8 est, €314-353.9M]

        • +5.7% ELIOR.FP (Elior Group) -- discloses terms of share buyback progamm

        • +5.0% DRW3.GR (Drägerwerk) -- final FY earnings in line with preliminary release: EPS €5.86 vs FactSet €4.97 [5 est, €4.55-5.32]

        • +5.0% ATORX.SS (Alligator Bioscience -- positive interim results from dose escalation portion of phase 1 study of alg.APV-527 in solid Tumors expressing Tumor antigen 5T4

        • +5.0% AAL.LN (Anglo American) -- upgraded to overweight from equal-weight at Morgan Stanley

        • +5.0% DOM.LN (Domino's Pizza Group) -- upgraded to buy from add at Peel Hunt

        • +4.9% BLV.FP (Believe) -- Warner Music Group was party indicating interest in Believe at at least €17/share

        • +4.6% ROVI.SM (Laboratorios Farmaceuticos Rovi, S.A.) -- has engaged Lazard to assess potential strategic alternatives

        • +4.5% SPX.LN (Spirax Group) -- FY adj EPS 311.8p vs consensus 312.0p; return to organic sales growth and adj operating profit margin progress expected in 2024

        • +3.8% DARK.LN (Darktrace) -- H1 EPS $0.08 vs FactSet $0.08 [3 est, $0.07-0.09]; now expects FY adj. EBITDA margin at least 21.0% vs prior between 18.0-20.0%

        • +2.7% KIE.LN (Kier Group) -- H1 adj. EPS 8.7p vs year-ago 8.5p; FactSet 8.6p [1 est]; declares interim dividend of 1.67p/share

        • +2.6% MTU.FP (Manitou BF) -- FY EPS €3.75 vs year-ago €1.43

        • +2.5% CGG.FP (CGG) -- final FY earnings inline with prelim. release: Adj. EBITDA $400M vs guidance $390-400M

          • On earnings/updates: CTPNV.NA (CTP), VIJ.GR (Viemed Healthcare), AVOL.SW (Avolta), KARN.SW (Kardex Holding), RF.FP (Eurazeo), TRMD.A.DC (TORM), GET.FP (Getlink), AV.LN (Aviva), RWA.LN (Robert Walters), GFTU.LN (Grafton Group) and reversing initial declines MRK.GR (Merck KGaA), FIA1S.FH (Finnair), PSM.GR (ProSiebenSat.1 Media)

      • Notable Decliners

        • -23.9% SAS.SS (SAS) -- Q1 net income (SEK1.45B) vs year-ago (SEK2.71B), reaffirms there'll be no value for existing shareholders as a result of Chapter 11 process; February traffic +8% y/y

        • -23.6% TIT.IM (Telecom Italia) -- approves 2024-2026 "Free to Run" industrial plan

        • -23.3% TEP.FP (Teleperformance) -- FY net income €602M vs FactSet €798.9M [16 est, €613.5-917M]

        • -13.3% BOSS.GR (Hugo Boss) -- Q4 EPS €1.23 vs FactSet €1.08; guides 2024 EBIT of €430-475M vs FactSet €492.24M

        • -10.6% PTSB.ID (Permanent TSB Group Holdings) -- FY Pretax income €79M vs FactSet €91.2M, provides 2024 outlook

        • -10.0% DEC.FP (JCDecaux) -- FY net income €209M vs FactSet €149.3M [10 est, €123.1-212.7M]

        • -8.3% INTRUM.SS (Intrum) -- downgraded to sell from hold at Arctic Securities

        • -7.7% GFT.GR (GFT Technologies) -- FY Adj EBIT €73.3M vs guidance €74-76M, FactSet €70.2M [5 est, €67.1-74.2M], 2024 guidance in line with consensus

        • -7.4% JMT.PL (Jeronimo Martins) -- FY net income attributable €756M, raises dividend +21.6% y/y; outlook muted

        • -4.7% ENT.LN (Entain) -- FY Adj. EPS 44.2p vs FactSet 41.2p [18 est, 37.8-44.9p]; YTD the group is trading in line with expectations

        • -4.5% BNR.GR (Brenntag) -- FY EPS €4.73 vs consensus €4.97; hikes divi by 5% and guides FY24

        • -4.5% SFER.IM (Salvatore Ferragamo) -- FY net income €26.2M vs FactSet €24.6M [15 est, €17.8-34.5M]

        • -3.6% ALPHA.GA (Alpha Services & Holdings) -- Q4 adjusted net income €215.8M vs FactSet €191M, guides 2024, 2025, 2026

        • -3.1% SAVE.SS (Nordnet) -- downgraded to hold from buy at SEB

        • -3.1% TYMN.LN (Tyman) -- FY operating profit £60.2M vs FactSet £72.0M [6 est, £64.4-84M]

        • -3.1% NEXI.IM (Nexi) -- FY normalized net income €711.8M vs FactSet €726.1M; To proposes up to €500M share buy-back program; guides 2024; shares recerse initial gains

        • -3.0% HAUTO.NO (Höegh Autoliners) -- February trading update

        • -2.9% KSC.GR (KPS)

          • reports delayed FY (2022/2023) earnings, Q1 of FY23/24 and FY guidance

          • to place up to 3.7M new shares at €1.15/share with selected investors (including existing major shareholders)

        • -2.7% G1A.GR (GEA Group) -- FY EPS €2.56 ex-items vs consensus €2.30, raises dividend, guides 2024; shares recers initial gains

        • -2.6% GTT.FP (Gaztransport & Technigaz) -- downgraded to hold from buy at Berenberg

        • -2.5% PIRC.IM (Pirelli & C.) -- downgraded to hold from buy at Kepler Cheuvreux; to neutral from outperform at BNP Paribas Exane

          • On earnings/updates: BRK.LN (Brooks MacDonald Group), ZAG.AV (Zumtobel Group), LHA.GR (Deutsche Lufthansa), CON.GR (Continental), MRO.LN (Melrose Industries), BEZ.LN (Beazley), HBR.LN (Harbour Energy), ELIS.FP (Elis), AZE.BB (Azelis Group), ADM.LN (Admiral Group) and reversing initial gains ELM.LN (Elementis), GLJ.GR (GRENKE), IR5B.ID (Irish Continental Group), AENA.SM (Aena S.M.E.), UQA.AV (UNIQA Insurance Group), UCG.IM (UniCredit)

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: Mithra Pharmaceuticals (MITRA.BB)

        • DACHs: Flughafen Zurich (FHZN.SW), mobilezone (MOZN.SW), Coltene (CLTN.SW), Mikron (MIKN.SW), Orell Füssli (OFN.SW), JDC Group (JDC.GR)

        • Nordics: Asetek (ASTK.NO)

        • UK/Ireland: Informa (INF.LN), Stelrad Group (SRAD.LN), FBD Holdings (EG7.ID)

  • Data:

    • Economics:

      • Switzerland Feb unemployment rate (sa) 2.2% vs consensus 2.2%, prior 2.2%; (nsa) 2.4% vs consensus 2.6%, prior 2.5%

      • Germany Jan factory orders (11.3%) m/m vs consensus (6.0%), prior revised +12.0% from +8.9%

      • UK Feb house price index +1.7% y/y vs consensus +2.3%, prior revised +2.3% from +2.5% - Halifax release

      • Denmark Jan manufacturing production (3.5%) m/m vs consensus (3.8%), prior (0.3%) from +5.7%

      • Norway Jan manufacturing production 0.0% m/m vs consensus +0.6%, prior +0.3%

    • Markets:

      • WTI Crude (Apr 24): ($0.28) or (0.35%) to $78.85

      • €-$ +0.0036 or +0.33% to 1.0933

      • £-$ +0.0059 or +0.46% to 1.2791

      • €-£ (0.0005) to 0.8550

      • S&P 500 +0.86%

      • Performance year-to-date:

        • FTSE 100: (0.53%)

        • DAX: +6.51%

        • CAC: +6.27%

        • MIB: +10.16%

        • Stoxx 600: +5.05%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE